Your browser doesn't support javascript.
loading
KVD900, an oral on-demand treatment for hereditary angioedema: Phase 1 study results.
Maetzel, Andreas; Smith, Michael D; Duckworth, Edward J; Hampton, Sally L; De Donatis, Gian Marco; Murugesan, Nivetha; Rushbrooke, Louise J; Li, Lily; Francombe, Danielle; Feener, Edward P; Yea, Christopher M.
Afiliación
  • Maetzel A; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass; Institute of Health Policy, Management & Evaluation, University of Toronto, Toronto, Ontario, Canada.
  • Smith MD; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass.
  • Duckworth EJ; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass.
  • Hampton SL; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass.
  • De Donatis GM; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass.
  • Murugesan N; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass.
  • Rushbrooke LJ; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass.
  • Li L; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass.
  • Francombe D; Simbec-Orion Ltd, Merthyr Tydfil, United Kingdom.
  • Feener EP; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass. Electronic address: epf@kalvista.com.
  • Yea CM; KalVista Pharmaceuticals, Salisbury and Cambridge, Mass.
J Allergy Clin Immunol ; 149(6): 2034-2042, 2022 06.
Article en En | MEDLINE | ID: mdl-35086692
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Angioedemas Hereditarios Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Humans / Male Idioma: En Revista: J Allergy Clin Immunol Año: 2022 Tipo del documento: Article País de afiliación: Canadá
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Angioedemas Hereditarios Tipo de estudio: Clinical_trials / Prognostic_studies Límite: Adult / Humans / Male Idioma: En Revista: J Allergy Clin Immunol Año: 2022 Tipo del documento: Article País de afiliación: Canadá